GF
NVO

Gabelli Funds’s Novo Nordisk NVO Stock Holding History

Gabelli Funds’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-35,048
Closed -$3.01M – 1103
2024
Q4 		$3.01M Hold
35,048
– – 0.02% 562
2024
Q3 		$4.17M Sell
35,048
-11,915
-25% -$1.59M 0.03% 502
2024
Q2 		$6.7M Buy
46,963
+12,363
+36% +$1.64M 0.05% 377
2024
Q1 		$4.44M Hold
34,600
– – 0.03% 484
2023
Q4 		$3.58M Hold
34,600
– – 0.03% 524
2023
Q3 		$3.15M Sell
34,600
-5,400
-14% -$476K 0.03% 552
2023
Q2 		$3.24M Hold
40,000
– – 0.02% 556
2023
Q1 		$3.18M Buy
40,000
+2,000
+5% +$142K 0.02% 568
2022
Q4 		$2.57M Buy
+38,000
New +$2.23M 0.02% 608
2020
Q4 		– Sell
-37,600
Closed -$1.3M – 1226
2020
Q3 		$1.3M Hold
37,600
– – 0.01% 767
2020
Q2 		$1.23M Buy
+37,600
New +$1.2M 0.01% 765

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Gabelli Funds's NVO Position: Q1 2025 in Review

Gabelli Funds sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 35,048 shares — an estimated $3.01M sold.

Gabelli Funds first reported a position in NVO in Q2 2020 and held it in 11 quarters. The position peaked at $6.7M in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Gabelli Funds reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Gabelli Funds sold 35,048 Novo Nordisk shares in Q1 2025, an estimated $3.01M.
  • Gabelli Funds first reported a position in Novo Nordisk in Q2 2020 and held it in 11 quarters.
  • Gabelli Funds's Novo Nordisk position peaked at $6.7M in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Gabelli Funds's 13F filing for Q1 2025, filed 14 May 2025.